BN Business News
Add your company to Business Communicator →

Business · 21/10/2004

NIH Seeks Exclusive License for Human Parvovirus B19 Vaccine

The National Institutes of Health is considering granting a worldwide exclusive license to practice certain inventions related to a Human Parvovirus B19 vaccine, including patents held by Viral Antigens, Inc.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights